Published in TB and Outbreaks Week, June 10th, 2003
"The diagnosis of latent tuberculosis infection relies on the tuberculin skin test (TST), which has many drawbacks," according to Katie Ewer and colleagues at the University of Oxford and the Institute of Health Sciences in Oxford, United Kingdom, the Leicestershire Health Authority in Leicestershire, and the Statens Serum Institute in Copenhagen, Denmark.
An enzyme-linked immunospot (ELISPOT) test developed by Ewer and coauthors proved more accurate than TST in identifying British schoolchildren with latent...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.